Altris AI
Overview
Altris AI is an AI-powered, cloud-based platform designed to assist eye care specialists in the interpretation and management of Optical Coherence Tomography (OCT) scans. The platform automates the analysis of OCT scans, capable of detecting over 70 retinal pathologies and more than 40 biomarkers, including conditions like glaucoma, Age-related Macular Degeneration (AMD), and diabetic retinopathy. It differentiates between pathological and non-pathological b-scans, aiming to enhance diagnostic accuracy and efficiency in retinal diagnostics. Altris AI offers a vendor-neutral Image Management System (IMS) that is compatible with OCT devices from nine leading manufacturers, allowing for the import, storage, and analysis of historical OCT data from various sources in one secure environment. The system supports quantitative analysis of disease progression through maps, graphs, and percentage-based insights, and can generate custom PDF reports. Beyond its core analysis capabilities, Altris AI also provides an educational mobile app, Altris Education OCT, which offers a vast database of labeled OCT scans for learning and training purposes. The platform is utilized by ophthalmologists, optometrists, and pharmaceutical companies to streamline workflows, support research, and improve patient outcomes.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automated OCT scan analysis
- Detection of 70+ retinal pathologies and 40+ biomarkers
- Vendor-neutral Image Management System (IMS) compatible with 9 OCT manufacturers
- Quantitative analysis of pathology progression (maps, graphs, percentages)
- Historical OCT data management and analysis
- Generate research-ready data in XLSX format
- Custom PDF report generation
- Streamlined collaboration and data sharing
- AI-powered retina layers segmentation
- Glaucoma risk analysis and optic disc assessment
Use Cases
- Accelerate research with AI ROU models
- Support research site eligibility workflows
- Gather analytics on biomarkers, patient imaging data, and treatment patterns
- Analyze large volumes of historical OCT data
- Power research on retinal biomarkers and conditions
- Support clinical research and trials
Details
| Category | Ophthalmology AI |
| Pricing | $249/per month — Starting at $249/Per Month. |
| Deployment | Cloud-based platform (web-based) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated In August 2023, Altris Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Altris IMS platform, an image and data management system for OCT scans. This clearance pertains to the platform's ability to store, organize, and support in-depth analysis of OCT scans. However, the advanced AI models for pathology detection and visualization are currently designated for Research Use Only in the USA and are not intended for diagnostic or clinical decision-making. |
| Integrations | |
| EHR | Not specified |
| Specialties | Ophthalmology |
What the Web Says
Altris AI is an AI-powered ophthalmic image management system designed to assist ophthalmologists and optometrists in interpreting Optical Coherence Tomography (OCT) scans. It helps differentiate pathological from non-pathological scans, identifies over 70 retina-related pathologies and biomarkers, and aims to improve diagnostic accuracy and efficiency in eye care.
Overall: PositiveStrengths
- Accelerates OCT examination, allowing more patients to be served.
- Increases confidence in defining pathologies, even rare ones, for less experienced ophthalmologists.
- Provides consistent diagnostic quality regardless of the specialist's experience.
- Seamless integration into existing hospital workflows.
- Offers features like severity detection, retina layer thickness analysis, and 3D modeling for surgical planning.
- FDA-cleared, CE-certified, and compliant with GDPR and HIPAA regulations.
Limitations
- One Reddit comment suggests that AI in general is still in development for diagnostics and has a high margin of error, though this is not specific to Altris AI.
- Some AI training platforms can be unstable or have lower pay, which might be a concern for those involved in developing or refining AI models, but this is not a direct con for the end-user product.
- A Reddit user mentioned that AI tools they tried for MRI scans (not Altris AI specifically) sometimes gave conflicting diagnoses.
Based on reviews from: G2, Software Advice, Altris AI Reviews, GetApp Australia, Capterra, Altris AI, Slashdot, Reddit, Review of Optometric Business, The Ophthalmologist
Last updated: 2026-08-15
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Altris AI
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Altris AI.
AI for Clinical Trials
Altris
Frequently Asked Questions
Investors who backed Altris AI
Funded through the company that built this tool.
